NDATOPICALSPONGE
Approved
Sep 2006
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 6h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DURAPREP is a topical antiseptic sponge containing iodine povacrylex and isopropyl alcohol, indicated for skin antisepsis prior to surgical procedures. It provides rapid and sustained antimicrobial activity on intact skin to reduce microbial flora and prevent surgical site infections. The product is applied directly to the surgical site as a pre-operative prep agent.
LOE Approaching
Product faces approaching loss of exclusivity with moderate competitive pressure (30%), suggesting potential team right-sizing and transition planning in coming years.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
DURAPREP currently shows zero linked job openings, reflecting its mature and stable commercial position with limited growth investment. Careers on this product focus on defending market share and managing the transition toward loss of exclusivity rather than growth-phase opportunities.
Brand ManagerField Sales Representative
Worked on DURAPREP at Solventum? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.